You are here » Home » Companies » Company Overview » Bharat Immunological & Biological Corporation Ltd

Bharat Immunological & Biological Corporation Ltd.

BSE: 524663 Sector: Health care
NSE: N.A. ISIN Code: INE994B01014
BSE LIVE 15:58 | 27 Apr 34.50 -0.25
(-0.72%)
OPEN

36.40

HIGH

36.60

LOW

33.05

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 36.40
PREVIOUS CLOSE 34.75
VOLUME 276669
52-Week high 37.40
52-Week low 16.65
P/E 42.07
Mkt Cap.(Rs cr) 148.97
Buy Price 0.00
Buy Qty 0.00
Sell Price 34.50
Sell Qty 3.00
OPEN 36.40
CLOSE 34.75
VOLUME 276669
52-Week high 37.40
52-Week low 16.65
P/E 42.07
Mkt Cap.(Rs cr) 148.97
Buy Price 0.00
Buy Qty 0.00
Sell Price 34.50
Sell Qty 3.00

Bharat Immunological & Biological Corporation Ltd. (BHARATIMMUNOLOG) - Company History

Incorporated in 1989 in Uttar Pradesh, Bharat Immunological & Biological Corporation (BIBCL) is in the business of manufacturing pharmaceutical formulations. The company's manufacturing unit is located in Bulandshahr district, Uttar Pradesh. BIBCL manufactures oral polio vaccine (OPV) for which it has installed a plant of 100 mln units. Commercial production of the OPV started from Jan'96. The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme. It has set up an R&D unit for the development of hepatitis B vaccine through transfer of technology from the US. The Company is planning to diversify into the production of vaccines pertaining to B.C.G, Measles and Tetanus Toxide.The company has been declared a SICK company by BIFR.